Close
Close
Treatment Database
Autologous enriched T-cells genetically modified with a retroviral vector to express two chimeric antigen receptors (CARs) targeting cluster of differentiation (CD) 19 and CD 22.
Trade Name not avaiable
Orphan Indication Acute Lymphoblastic Leukemia
USA Market Approval
USA Designation Date 17-04-2019
Sponsor Autolus Limited
Forest House, 58 Wood Lane
London
More about Acute lymphoblastic leukemia
Free Newsletter
Related Videos
by Abidemi Uruejoma
537 views